Skip to main content
. 2014 Oct 20;2014:364316. doi: 10.1155/2014/364316

Figure 5.

Figure 5

Evaluation of serums let-7i-3p and miR-154-5p as potential biomarkers of smoking-related lung cancer. Receiver operating characteristic (ROC) curve analyses of serums let-7i-3p (a) and miR-154-5p (b) were performed to discriminate patients with smoking-related lung cancer from nonsmokers. The AUCs for serums let-7i-3p and miR-154-5p were 0.892 and 0.957, respectively.